Affiliation:
1. Analytical Research & Development, Merck & Co., Inc., Rahway, NJ 07065, USA
Abstract
Polysorbates 20 and 80 (PS20 and PS80) are added to many commercial biologic and vaccine pharmaceuticals. It is commonly known that these polysorbates undergo a radical oxidation mechanism; however, the identity of these radical intermediates has not been clearly determined. Furthermore, PS20 and PS80 differ by the presence of a lauric acid instead of an oleic acid, respectively. The oxidation of PS80 is thought to be centered around the double bond of the oleic acid even though PS20 also undergoes oxidation, making the mechanism of oxidation unclear for PS20. Using commercial stocks of PS20 and PS80 alkyl (R•), alkoxyl (C-O•) and peroxyl (C-OO•) radicals were detected by electron paramagnetic resonance spectroscopy likely originating from radical-initiating species already present in the material. When dissolved in water, the peroxyl radicals (C-OO•) originally in the stocks were not detected but poly(ethylene oxide) radicals were. An oxidative pathway for polysorbates was suggested based on the radical species identified in the polysorbate stock material and solutions.
Reference44 articles.
1. Ionova, Y., and Wilson, L. (2020). Biologic excipients: Importance of clinical awareness of inactive ingredients. PLoS ONE, 15.
2. A rapid and simple screening method to identify conditions for enhanced stability of modular vaccine candidates;Tekewe;Biochem. Eng. J.,2015
3. Development of a fully water-dilutable mint concentrate based on a food-approved microemulsion;Benkert;Food Chem.,2022
4. Effect of Surfactants on Mechanical, Thermal, and Photostability of a Monoclonal Antibody;Agarkhed;AAPS PharmSciTech,2018
5. Cottrell, T., and Peij, J.V. (2015). Emulsifiers in Food Technology, John Wiley & Sons. [2nd ed.].